Skip to content
Feed/RSP2024/3011(RSP)Health & Social

Regulation on the market of products containing, consisting of or produced from genetically modified maize MON 95275 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council

COMCMT1R-EP1R-C2R-EPCNCADO
Rapporteur Biljana BORZANCommittee ENVIUpdated 15mo ago
View source

This resolution expresses the European Parliament's objection to authorising genetically modified maize MON 95275 for use in food and animal feed within the EU. The objection affects companies seeking to market products derived from this specific genetically modified maize, as well as consumers and farmers who would potentially use these products. The Parliament argues that the draft authorisation exceeds the Commission's powers and is inconsistent with EU law's aim to ensure a high level of protection for human health, animal welfare, and the environment. Concerns include insufficient data on unintended genetic effects, potential impacts on non-target organisms, gene flow risks, and inadequate monitoring requirements, echoing previous objections to GMO authorisations.

AI-generated·5 Apr 2026·Source document·Unverified

An application was submitted for placing on the market of foods, food ingredients, and feed containing or produced from genetically modified maize MON 95275.

What changes

  • The European Parliament calls on the Commission to withdraw its draft implementing decision for authorising genetically modified maize MON 95275.
  • The Parliament requests the Commission to submit a new draft implementing decision to the committee.
  • The Commission is called upon not to authorise the GM crops due to risks to biodiversity, food safety, and workers’ health.

Expected impact

  • The draft Commission implementing decision is considered not consistent with Union law and exceeds implementing powers provided for in Regulation (EC) No 1829/2003.
  • Concerns are raised about the potential for gene flow to wild relatives, leading to transgene persistence and ecological imbalance.
  • The use of insecticidal GM crops leads to continuous exposure of organisms to toxins, unlike the limited exposure from spraying insecticides.

Limitations

  • The document is a resolution of the European Parliament and does not contain the full Commission implementing decision or the EFSA scientific opinion, limiting the ability to analyze the specific technical details of the authorisation process.
  • The document does not provide specific details on the economic impact of authorising or not authorising the GM maize MON 95275.

Some data sources haven't been updated in over 48 hours.

assemblee_nationalejust now
audit_findings3d ago
austria_lobby_registerjust now
belgium_lobby_registerjust now
bundestagjust now
bundestag_lobby_registerjust now
camera_deputatijust now
cap_payments3d ago
chambrejust now
cohesion_financejust now
congresojust now
cordis3d ago
council_positions3d ago
denmark_lobby_registerjust now
desi3d ago
ec_commissioner_meetingsnever
eduskuntajust now
eea3d ago
eib_projectsjust now
ep_draft_agenda1d ago
ep_open_data_meps3h ago
esif3d ago
european_council_summits3d ago
eurostat3d ago
eurostat_cofogjust now
eu_transparency_register3h ago
finland_lobby_registerjust now
folketingetjust now
folketinget-calendar4d ago
fts3d ago
hatvp_lobby_registerjust now
howtheyvote_votesjust now
ireland_lobby_registerjust now
lobbyfactsjust now
nationalratjust now
nationalrat-calendar4d ago
netherlands_lobby_registerjust now
oeil_legislative_proceduresjust now
oireachtasjust now
plenary_agendajust now
public_consultations3d ago
riigikogujust now
riksdagjust now
rrf_allocationsjust now
sejmjust now
spain_lobby_registerjust now
sweden_lobby_registerjust now
ted_procurementjust now
transposition_tracker1d ago
tweede_kamerjust now
wikidata_parliaments13d ago